Coronavirus Test Kits Market in APAC 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	149 Pages	TechNavio	October, 2023	INF18250121

Best Price Guarantee
Price	from $2,500
Length	149 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18250121

Test Kits Market In APAC 2023-2027

Technavio has been monitoring the test kits market in APAC and is forecast to decline by USD -12.48 bn during 2022-2027, decelerating at a CAGR of -24.44% during the forecast period. Our report on the test kits market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a rise in the availability of various types of test kits in APAC, growing awareness and importance of early detection, and implementation of mass testing programs by governments.

Technavio's test kits market in APAC is segmented as below:

By End-user

Government
Non-government

By Type

Rapid test kit
RT-PCR
Others

This study identifies the advancements in technology to develop rapid and accurate test kits as one of the prime reasons driving the test kits market in APAC growth during the next few years. Also, the advent of sars-cov-2 mutation and rise in the adoption of business strategies by vendors will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the test kits market in APAC covers the following areas:

Test kits market in APAC sizing
Test kits market in APAC forecast
Test kits market in APAC industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading test kits market in APAC vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Group, Bio Rad Laboratories Inc., CAMTECH DIAGNOSTICS, Co Diagnostics Inc., Danaher Corp., Denka Co. Ltd., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., Genes2Me Pvt. Ltd., Guangzhou Wondfo Biotech Co. Ltd., Hologic Inc., JN Medsys Pte. Ltd., KogeneBiotech, Kurabo Industries Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, Sd Biosensor Inc., Seegene Inc., SolGent Co. Ltd., Sysmex Corp., Tata Sons Pvt. Ltd., and Thermo Fisher Scientific Inc.. Also, the test kits market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Type; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on APAC - Market size and forecast 2022-2027 ($ billion); Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibit 16: Chart on APAC: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
4 Five Forces Analysis: 4.1 Five forces summary; Exhibit 18: Five forces analysis - Comparison between 2022 and 2027; 4.2 Bargaining power of buyers; Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 4.3 Bargaining power of suppliers; Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 4.4 Threat of new entrants; Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027; 4.5 Threat of substitutes; Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027; 4.6 Threat of rivalry; Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027; 4.7 Market condition; Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
5 Market Segmentation by End-user: 5.1 Market segments; Exhibit 25: Chart on End-user - Market share 2022-2027 (%); Exhibit 26: Data Table on End-user - Market share 2022-2027 (%); 5.2 Comparison by End-user; Exhibit 27: Chart on Comparison by End-user; Exhibit 28: Data Table on Comparison by End-user; 5.3 Government - Market size and forecast 2022-2027; Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion); Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion); Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%); Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%); 5.4 Non-government - Market size and forecast 2022-2027; Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%); Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%); 5.5 Market opportunity by End-user; Exhibit 37: Market opportunity by End-user ($ billion); Exhibit 38: Data Table on Market opportunity by End-user ($ billion)
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 39: Chart on Type - Market share 2022-2027 (%); Exhibit 40: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 41: Chart on Comparison by Type; Exhibit 42: Data Table on Comparison by Type; 6.3 Rapid test kit - Market size and forecast 2022-2027; Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%); 6.4 RT-PCR - Market size and forecast 2022-2027; Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%); 6.5 Others - Market size and forecast 2022-2027; Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%); 6.6 Market opportunity by Type; Exhibit 55: Market opportunity by Type ($ billion); Exhibit 56: Data Table on Market opportunity by Type ($ billion)
7 Customer Landscape: 7.1 Customer landscape overview; Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%); 8.2 Geographic comparison; Exhibit 60: Chart on Geographic comparison; Exhibit 61: Data Table on Geographic comparison; 8.3 India - Market size and forecast 2022-2027; Exhibit 62: Chart on India - Market size and forecast 2022-2027 ($ billion); Exhibit 63: Data Table on India - Market size and forecast 2022-2027 ($ billion); Exhibit 64: Chart on India - Year-over-year growth 2022-2027 (%); Exhibit 65: Data Table on India - Year-over-year growth 2022-2027 (%); 8.4 China - Market size and forecast 2022-2027; Exhibit 66: Chart on China - Market size and forecast 2022-2027 ($ billion); Exhibit 67: Data Table on China - Market size and forecast 2022-2027 ($ billion); Exhibit 68: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 69: Data Table on China - Year-over-year growth 2022-2027 (%); 8.5 Japan - Market size and forecast 2022-2027; Exhibit 70: Chart on Japan - Market size and forecast 2022-2027 ($ billion); Exhibit 71: Data Table on Japan - Market size and forecast 2022-2027 ($ billion); Exhibit 72: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibit 73: Data Table on Japan - Year-over-year growth 2022-2027 (%); 8.6 South Korea - Market size and forecast 2022-2027; Exhibit 74: Chart on South Korea - Market size and forecast 2022-2027 ($ billion); Exhibit 75: Data Table on South Korea - Market size and forecast 2022-2027 ($ billion); Exhibit 76: Chart on South Korea - Year-over-year growth 2022-2027 (%); Exhibit 77: Data Table on South Korea - Year-over-year growth 2022-2027 (%); 8.7 Rest of APAC - Market size and forecast 2022-2027; Exhibit 78: Chart on Rest of APAC - Market size and forecast 2022-2027 ($ billion); Exhibit 79: Data Table on Rest of APAC - Market size and forecast 2022-2027 ($ billion); Exhibit 80: Chart on Rest of APAC - Year-over-year growth 2022-2027 (%); Exhibit 81: Data Table on Rest of APAC - Year-over-year growth 2022-2027 (%); 8.8 Market opportunity By Geographical Landscape; Exhibit 82: Market opportunity By Geographical Landscape ($ billion); Exhibit 83: Data Table on Market opportunity By Geographical Landscape ($ billion)
9 Drivers, Challenges, and Trends: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Exhibit 84: Impact of drivers and challenges in 2022 and 2027; 9.4 Market trends
10 Vendor Landscape: 10.1 Overview; 10.2 Vendor landscape; Exhibit 85: Overview on Criticality of inputs and Factors of differentiation; 10.3 Landscape disruption; Exhibit 86: Overview on factors of disruption; 10.4 Industry risks; Exhibit 87: Impact of key risks on business
11 Vendor Analysis: 11.1 Vendors covered; Exhibit 88: Vendors covered; 11.2 Market positioning of vendors; Exhibit 89: Matrix on vendor position and classification; 11.3 3D Biomedicine Science and Technology Co. Ltd.; Exhibit 90: 3D Biomedicine Science and Technology Co. Ltd. - Overview; Exhibit 91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service; Exhibit 92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings; 11.4 Abbott Laboratories; Exhibit 93: Abbott Laboratories - Overview; Exhibit 94: Abbott Laboratories - Business segments; Exhibit 95: Abbott Laboratories - Key news; Exhibit 96: Abbott Laboratories - Key offerings; Exhibit 97: Abbott Laboratories - Segment focus; 11.5 altona Diagnostics GmbH; Exhibit 98: altona Diagnostics GmbH - Overview; Exhibit 99: altona Diagnostics GmbH - Product / Service; Exhibit 100: altona Diagnostics GmbH - Key offerings; 11.6 BGI Group; Exhibit 101: BGI Group - Overview; Exhibit 102: BGI Group - Product / Service; Exhibit 103: BGI Group - Key offerings; 11.7 Bio Rad Laboratories Inc.; Exhibit 104: Bio Rad Laboratories Inc. - Overview; Exhibit 105: Bio Rad Laboratories Inc. - Business segments; Exhibit 106: Bio Rad Laboratories Inc. - Key news; Exhibit 107: Bio Rad Laboratories Inc. - Key offerings; Exhibit 108: Bio Rad Laboratories Inc. - Segment focus; 11.8 Co Diagnostics Inc.; Exhibit 109: Co Diagnostics Inc. - Overview; Exhibit 110: Co Diagnostics Inc. - Product / Service; Exhibit 111: Co Diagnostics Inc. - Key news; Exhibit 112: Co Diagnostics Inc. - Key offerings; 11.9 Denka Co. Ltd.; Exhibit 113: Denka Co. Ltd. - Overview; Exhibit 114: Denka Co. Ltd. - Business segments; Exhibit 115: Denka Co. Ltd. - Key news; Exhibit 116: Denka Co. Ltd. - Key offerings; Exhibit 117: Denka Co. Ltd. - Segment focus; 11.10 Edinburgh Genetics Ltd.; Exhibit 118: Edinburgh Genetics Ltd. - Overview; Exhibit 119: Edinburgh Genetics Ltd. - Product / Service; Exhibit 120: Edinburgh Genetics Ltd. - Key offerings; 11.11 F. Hoffmann La Roche Ltd.; Exhibit 121: F. Hoffmann La Roche Ltd. - Overview; Exhibit 122: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 123: F. Hoffmann La Roche Ltd. - Key news; Exhibit 124: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 125: F. Hoffmann La Roche Ltd. - Segment focus; 11.12 Guangzhou Wondfo Biotech Co. Ltd.; Exhibit 126: Guangzhou Wondfo Biotech Co. Ltd. - Overview; Exhibit 127: Guangzhou Wondfo Biotech Co. Ltd. - Product / Service; Exhibit 128: Guangzhou Wondfo Biotech Co. Ltd. - Key offerings; 11.13 Hologic Inc.; Exhibit 129: Hologic Inc. - Overview; Exhibit 130: Hologic Inc. - Business segments; Exhibit 131: Hologic Inc. - Key news; Exhibit 132: Hologic Inc. - Key offerings; Exhibit 133: Hologic Inc. - Segment focus; 11.14 Maccura Biotechnology Co. Ltd.; Exhibit 134: Maccura Biotechnology Co. Ltd. - Overview; Exhibit 135: Maccura Biotechnology Co. Ltd. - Product / Service; Exhibit 136: Maccura Biotechnology Co. Ltd. - Key offerings; 11.15 Mylab Discovery Solutions Pvt Ltd.; Exhibit 137: Mylab Discovery Solutions Pvt Ltd. - Overview; Exhibit 138: Mylab Discovery Solutions Pvt Ltd. - Product / Service; Exhibit 139: Mylab Discovery Solutions Pvt Ltd. - Key offerings; 11.16 QIAGEN NV; Exhibit 140: QIAGEN NV - Overview; Exhibit 141: QIAGEN NV - Product / Service; Exhibit 142: QIAGEN NV - Key news; Exhibit 143: QIAGEN NV - Key offerings; 11.17 Thermo Fisher Scientific Inc.; Exhibit 144: Thermo Fisher Scientific Inc. - Overview; Exhibit 145: Thermo Fisher Scientific Inc. - Business segments; Exhibit 146: Thermo Fisher Scientific Inc. - Key news; Exhibit 147: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 148: Thermo Fisher Scientific Inc. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Exhibit 149: Inclusions checklist; Exhibit 150: Exclusions checklist; 12.3 Currency conversion rates for US$; Exhibit 151: Currency conversion rates for US$; 12.4 Research methodology; Exhibit 152: Research methodology; Exhibit 153: Validation techniques employed for market sizing; Exhibit 154: Information sources; 12.5 List of abbreviations; Exhibit 155: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on APAC - Market size and forecast 2022-2027 ($ billion); Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibits16: Chart on APAC: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibits18: Five forces analysis - Comparison between 2022 and 2027; Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits21: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits22: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits23: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits24: Chart on Market condition - Five forces 2022 and 2027; Exhibits25: Chart on End-user - Market share 2022-2027 (%); Exhibits26: Data Table on End-user - Market share 2022-2027 (%); Exhibits27: Chart on Comparison by End-user; Exhibits28: Data Table on Comparison by End-user; Exhibits29: Chart on Government - Market size and forecast 2022-2027 ($ billion); Exhibits30: Data Table on Government - Market size and forecast 2022-2027 ($ billion); Exhibits31: Chart on Government - Year-over-year growth 2022-2027 (%); Exhibits32: Data Table on Government - Year-over-year growth 2022-2027 (%); Exhibits33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibits34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibits35: Chart on Non-government - Year-over-year growth 2022-2027 (%); Exhibits36: Data Table on Non-government - Year-over-year growth 2022-2027 (%); Exhibits37: Market opportunity by End-user ($ billion); Exhibits38: Data Table on Market opportunity by End-user ($ billion); Exhibits39: Chart on Type - Market share 2022-2027 (%); Exhibits40: Data Table on Type - Market share 2022-2027 (%); Exhibits41: Chart on Comparison by Type; Exhibits42: Data Table on Comparison by Type; Exhibits43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibits44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibits45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibits46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibits47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibits48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibits49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibits50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits55: Market opportunity by Type ($ billion); Exhibits56: Data Table on Market opportunity by Type ($ billion); Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits58: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibits59: Data Table on Market share By Geographical Landscape - 2022-2027 (%); Exhibits60: Chart on Geographic comparison; Exhibits61: Data Table on Geographic comparison; Exhibits62: Chart on India - Market size and forecast 2022-2027 ($ billion); Exhibits63: Data Table on India - Market size and forecast 2022-2027 ($ billion); Exhibits64: Chart on India - Year-over-year growth 2022-2027 (%); Exhibits65: Data Table on India - Year-over-year growth 2022-2027 (%); Exhibits66: Chart on China - Market size and forecast 2022-2027 ($ billion); Exhibits67: Data Table on China - Market size and forecast 2022-2027 ($ billion); Exhibits68: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits69: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits70: Chart on Japan - Market size and forecast 2022-2027 ($ billion); Exhibits71: Data Table on Japan - Market size and forecast 2022-2027 ($ billion); Exhibits72: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibits73: Data Table on Japan - Year-over-year growth 2022-2027 (%); Exhibits74: Chart on South Korea - Market size and forecast 2022-2027 ($ billion); Exhibits75: Data Table on South Korea - Market size and forecast 2022-2027 ($ billion); Exhibits76: Chart on South Korea - Year-over-year growth 2022-2027 (%); Exhibits77: Data Table on South Korea - Year-over-year growth 2022-2027 (%); Exhibits78: Chart on Rest of APAC - Market size and forecast 2022-2027 ($ billion); Exhibits79: Data Table on Rest of APAC - Market size and forecast 2022-2027 ($ billion); Exhibits80: Chart on Rest of APAC - Year-over-year growth 2022-2027 (%); Exhibits81: Data Table on Rest of APAC - Year-over-year growth 2022-2027 (%); Exhibits82: Market opportunity By Geographical Landscape ($ billion); Exhibits83: Data Table on Market opportunity By Geographical Landscape ($ billion); Exhibits84: Impact of drivers and challenges in 2022 and 2027; Exhibits85: Overview on Criticality of inputs and Factors of differentiation; Exhibits86: Overview on factors of disruption; Exhibits87: Impact of key risks on business; Exhibits88: Vendors covered; Exhibits89: Matrix on vendor position and classification; Exhibits90: 3D Biomedicine Science and Technology Co. Ltd. - Overview; Exhibits91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service; Exhibits92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings; Exhibits93: Abbott Laboratories - Overview; Exhibits94: Abbott Laboratories - Business segments; Exhibits95: Abbott Laboratories - Key news; Exhibits96: Abbott Laboratories - Key offerings; Exhibits97: Abbott Laboratories - Segment focus; Exhibits98: altona Diagnostics GmbH - Overview; Exhibits99: altona Diagnostics GmbH - Product / Service; Exhibits100: altona Diagnostics GmbH - Key offerings; Exhibits101: BGI Group - Overview; Exhibits102: BGI Group - Product / Service; Exhibits103: BGI Group - Key offerings; Exhibits104: Bio Rad Laboratories Inc. - Overview; Exhibits105: Bio Rad Laboratories Inc. - Business segments; Exhibits106: Bio Rad Laboratories Inc. - Key news; Exhibits107: Bio Rad Laboratories Inc. - Key offerings; Exhibits108: Bio Rad Laboratories Inc. - Segment focus; Exhibits109: Co Diagnostics Inc. - Overview; Exhibits110: Co Diagnostics Inc. - Product / Service; Exhibits111: Co Diagnostics Inc. - Key news; Exhibits112: Co Diagnostics Inc. - Key offerings; Exhibits113: Denka Co. Ltd. - Overview; Exhibits114: Denka Co. Ltd. - Business segments; Exhibits115: Denka Co. Ltd. - Key news; Exhibits116: Denka Co. Ltd. - Key offerings; Exhibits117: Denka Co. Ltd. - Segment focus; Exhibits118: Edinburgh Genetics Ltd. - Overview; Exhibits119: Edinburgh Genetics Ltd. - Product / Service; Exhibits120: Edinburgh Genetics Ltd. - Key offerings; Exhibits121: F. Hoffmann La Roche Ltd. - Overview; Exhibits122: F. Hoffmann La Roche Ltd. - Business segments; Exhibits123: F. Hoffmann La Roche Ltd. - Key news; Exhibits124: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits125: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits126: Guangzhou Wondfo Biotech Co. Ltd. - Overview; Exhibits127: Guangzhou Wondfo Biotech Co. Ltd. - Product / Service; Exhibits128: Guangzhou Wondfo Biotech Co. Ltd. - Key offerings; Exhibits129: Hologic Inc. - Overview; Exhibits130: Hologic Inc. - Business segments; Exhibits131: Hologic Inc. - Key news; Exhibits132: Hologic Inc. - Key offerings; Exhibits133: Hologic Inc. - Segment focus; Exhibits134: Maccura Biotechnology Co. Ltd. - Overview; Exhibits135: Maccura Biotechnology Co. Ltd. - Product / Service; Exhibits136: Maccura Biotechnology Co. Ltd. - Key offerings; Exhibits137: Mylab Discovery Solutions Pvt Ltd. - Overview; Exhibits138: Mylab Discovery Solutions Pvt Ltd. - Product / Service; Exhibits139: Mylab Discovery Solutions Pvt Ltd. - Key offerings; Exhibits140: QIAGEN NV - Overview; Exhibits141: QIAGEN NV - Product / Service; Exhibits142: QIAGEN NV - Key news; Exhibits143: QIAGEN NV - Key offerings; Exhibits144: Thermo Fisher Scientific Inc. - Overview; Exhibits145: Thermo Fisher Scientific Inc. - Business segments; Exhibits146: Thermo Fisher Scientific Inc. - Key news; Exhibits147: Thermo Fisher Scientific Inc. - Key offerings; Exhibits148: Thermo Fisher Scientific Inc. - Segment focus; Exhibits149: Inclusions checklist; Exhibits150: Exclusions checklist; Exhibits151: Currency conversion rates for US$; Exhibits152: Research methodology; Exhibits153: Validation techniques employed for market sizing; Exhibits154: Information sources; Exhibits155: List of abbreviations